SUSY VARGHESE: Open Payments
NPI 1699161125 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $146 |
| Amgen Inc. | 1 | $138 |
| ABIOMED | 1 | $126 |
| Corcept Therapeutics | 1 | $123 |
| Gilead Sciences, Inc. | 2 | $112 |
| Smith+Nephew, Inc. | 1 | $24 |
Products named: PROCLAIM, Korlym, Epclusa, Livdelzi, STRAVIX PL.
Industry payments across TX — which companies pay providers there.
